"
Cisplatin Inhibits AhR Activation"
written by Erina Sasaki-Kudoh, Ikuru Kudo, Yuka Kakizaki, Miki Hosaka, Shun-Ichi Ikeda, Seiya Uemura, Ewa Grave, Shuntaro Togashi, Taku Sugawara, Hiroaki Shimizu, Hideaki Itoh,
published by
American Journal of Molecular Biology,
Vol.8 No.1, 2018
has been cited by the following article(s):
|
[1]
|
Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities
Journal of Enzyme Inhibition and Medicinal Chemistry,
2024
DOI:10.1080/14756366.2023.2286925
|
|
|
|
|
[2]
|
The components of the AhR‐molecular chaperone complex differ depending on whether the ligands are toxic or non‐toxic
FEBS Letters,
2024
DOI:10.1002/1873-3468.14871
|
|
|
|
|
[3]
|
Cryo-EM structure of the cytosolic AhR complex
Structure,
2023
DOI:10.1016/j.str.2022.12.013
|
|
|
|
|
[4]
|
Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?
Naunyn-Schmiedeberg's Archives of Pharmacology,
2021
DOI:10.1007/s00210-021-02112-3
|
|
|
|
|
[5]
|
Biochemical properties of human full-length aryl hydrocarbon receptor (AhR)
The Journal of Biochemistry,
2020
DOI:10.1093/jb/mvaa047
|
|
|
|
|
[6]
|
How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression
International Journal of Molecular Sciences,
2020
DOI:10.3390/ijms22010387
|
|
|
|
|
[7]
|
Unexpected therapeutic effects of cisplatin
Metallomics,
2019
DOI:10.1039/c9mt00049f
|
|
|
|